Decoy Therapeutics, Inc.
CAMBRIDGE, MA · CIK 0002065438 · Biotech · Public
Peptide conjugate therapeutics engineered for targeted drug delivery
decoytx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $1.0M
- 1 Form D · Apr 2025
- 17 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 21
- 1 granted · 20 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,020,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2567 | Ichor Microbial Solutions, Inc. | — | $1.1M |
| 2568 | WAYPATH PHARMA LLC | — | — |
| 2569 | SENEX BIOTECHNOLOGY, INC. | — | $1.0M |
| 2570 | Decoy Therapeutics, Inc. | — | $1.0M |
| 2571 | NEW HORIZON BIOTECH INC | — | — |
| 2572 | AMPLION INC. | — | $1.0M |
| 2573 | Biosceptre International Ltd | — | $1.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Barbara HibnerDirector · Executive Officer
- Michael LippExecutive Officer
- Peter MarschelDirector · Executive Officer
- Frederick PierceDirector · Executive Officer
Patents
- Anti-Viral Therapeutic Peptides, Conjugates, and Methods of Use Thereofapplication
- Methods For Reducing Or Preventing SARS-COV-2 Infection And Transmissionapplication
- Methods and Compositions for Treating Infectionsapplication
- Methods And Compositions For Treating Infectionsgranted
- Methods And Compositions For Treating Covid Infectionsapplication
- Methods For Reducing Or Preventing SARS-COV-2 Infection And Transmissionapplication
- Methods For Making Peptide Conjugates And The Product Made Therefromapplication
- Formulation of Antiviral Peptide Conjugatesapplication
- Anti-viral Therapeutic Peptides, Conjugates, And Methods Of Use Thereofapplication
- Methods For Reducing Or Preventing SARS-COV-2 Infection And Transmissionapplication
- Methods And Compositions For Treating Covid Infectionsapplication
- Methods and Compositions for Treating Infectionsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.